Mayne Pharma Group Limited announced that non-executive director Mr. Phil Hodges will not be standing for re-election as a Director of the Company at the upcoming Annual General Meeting, to be held on 29 November 2018. In accordance with the Company's constitution, Mr. Hodges will retire as a Director effective at the Annual General Meeting. Mr. Hodges joined the Mayne Pharma Board in November 2012 following the acquisition of Metrics Inc. which he founded and has also served on the Company's Science, Technology and Medical Committee.